A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma
A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma have?
A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma has 72 citations in the OpenAlex counts ScholarIQ stores.
When was A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma published?
A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma has 2021 year in the ScholarIQ index.
What is the open-access status of A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma?
A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma has hybrid oa status in the ScholarIQ index.
What is the DOI of A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma?
The DOI for A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma is on the source record.
What is the PMID of A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma?
The PMID for A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma is on the source record.
What is the OpenAlex record for A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma?
The OpenAlex for A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma is on the source record.